Allevio Pain Management Clinic   Report issue

Academic/Hospital Phase 4
Founded: Toronto Canada (2011)

Organization Overview

First Clinical Trial
2018
NCT04123652
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Allevio Pain Management Clinic

Active Ingredients

Drugs in Phase 4 Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 4)

Fibromyalgia (Phase 4)

Myofascial Pain Syndromes (Phase 4)

Neuralgia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1